Blackbird - Associate Director, Patient Recruitment & Engagement

<div class="content-intro"><p><strong>About Raven:</strong><br>We are Raven, RA Capital’s healthcare incubator. From discovery to delivery, whether we incubate, accelerate or rejuvenate, Raven’s goal is to turn scientific breakthroughs into transformative therapies and get them quickly, safely and efficiently to the patients that need them most. Raven’s experienced scientists, operators, and healthcare innovators have deep sector expertise across therapeutics, diagnostics, devices and services. They have brought hundreds of therapeutics into development, managed hospital systems, optimized clinical trials and navigated payor and regulatory systems to deliver patient impact - and they are ready to work with you.<br><br><strong>About RA Capital:</strong><br>Founded in 2004, RA Capital Management is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare, life sciences, and planetary health companies. RA Capital creates and funds innovative companies, from private seed rounds to public follow-on financings, allowing management teams to drive value creation from inception through commercialization and beyond. RA Capital's knowledge engine is guided by our Tech Atlas internal research division, and Raven, RA Capital’s company building team, offers entrepreneurs and innovators a collaborative and comprehensive platform to explore the novel and the re-imagined. RA Capital has more than 150 employees and over $10 billion in assets under management.</p></div><p><strong>About Blackbird:</strong><br>Blackbird is an integrated development team comprised of Clinical Development, Operations, Regulatory and Patient Engagement within Raven Venture Capital, part of RA Capital Management. Blackbird’s mission to transform clinical trial planning and execution, resulting in lower costs and expedited timelines across RA Capital’s portfolio. Blackbird provides companies with strategic, data-driven clinical study design assessments, operational optimizations, and innovative best practices to minimize inefficiencies and prevent the need to “reinvent the wheel” at each portfolio company.</p> <p> </p> <p data-start="461" data-end="471"><strong>The Role</strong></p> <p data-start="473" data-end="890">This is a high-impact operational leadership role. You will be responsible for the "last mile" of clinical development: ensuring our biotech portfolio companies can find, enroll, and retain diverse patient populations at record speeds. You will primarily consult with and advise companies during planning and enrollment, bringing innovative and curated strategies into implementation on behalf of portfolio companies. You will also have the opportunity to work on internal initiatives, such as building new technologies to solve industry challenges or partnering with the broader firm to identify disease areas with unmet needs for potential drug development.</p> <p data-start="1140" data-end="1162">Key Responsibilities</p> <ol data-start="1164" data-end="1205"> <li data-start="1164" data-end="1205"> <p data-start="1167" data-end="1205">Enrollment Strategy and Optimization</p> </li> </ol> <ul data-start="1207" data-end="2017"> <li data-start="1207" data-end="1503"> <p data-start="1209" data-end="1503">Portfolio Consultation: Partner with portfolio CEOs and Heads of Clinical Operations to design comprehensive recruitment and retention plans for Phase I-III programs. In some cases, you will serve as the de facto Head of Patient Engagement or Patient Recruitment at a startup biotech company.</p> </li> <li data-start="1207" data-end="1503"> <p data-start="1209" data-end="1503">Recruitment Difficulty Analysis: Conduct burden audits of protocols to identify why patients may decline participation or become an attrition risk. Implement protocol design recommendations and logistical solutions.</p> </li> <li data-start="1724" data-end="2017"> <p data-start="1726" data-end="2017">Central Recruitment Campaign Implementation: Over ... (truncated, view full listing at source)